WORLD-CLASS SPEAKER FACULTY

Alexandre Reuben

Assistant Professor

The University of Texas MD Anderson Cancer Center

Dolores Schendel

Chief Executive Officer & Chief Scientific Officer

Medigene AG

Laurence Cooper

Chief Executive Officer

Ziopharm Oncology, Inc

Marc Mansour

Chief Scientific Officer

Vaximm

Russell Pachynski

Assistant Professor, Division of Oncology

Washington University School of Medicine

Wouter Scheper

Senior postdoc, Haanen lab

Netherlands Cancer Institute

Philip Arlen

President & Chief Executive Officer

Precision Biologics

Enikő Tőke

Chief Scientific Officer

Treos Bio

Hideho Okada

Professor

University of California San Francisco

Stanley Leon

Professor Emeritus of Surgery

University of California, San Francisco School

Michal Bassani-Sternberg

Group leader, Ludwig Institute for Cancer Research

University Hospital of Lausanne and the University of Lausanne

Eli Gilboa

Professor of Microbiology & Immunology

University of Miami

Sijme Zeilemaker

Chief Operating Officer

Immunicum

Lei Zheng

Professor

John Hopkins School of Medicine

TJ Langer

Chief Executive Officer & President

Myst Therapeutics

Marit van Buuren

Director, T-cell Immunology

Neon Therapeutics

Nicolas Poirier

Chief Scientific Officer

OSE Immunotherapeutics

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

Jessica Fletchner

Chief Scientific Officer

Genocea

Narinder Singh

Senior Vice President, Pharmaceutical Sciences & Manufacturing

Genocea

Raymond Miller

Senior Global Product Manager, Therapeutic Materials

GenScript Biotech Corporation

Thomas Davis

Chief Medical Officer

Genocea Biosciences

Peter Joyce

Chief Executive Officer, Co-Founder

Grey Wolf Therapeutics

Gerben Zondag

Chief Executive Officer

Immunetune

Gad Berdugo

Chief Executive Officer & Co-Founder

EpiVax Oncology, Inc.

Guilhem Richard

Lead Computational Immunologist

EpiVax Oncology

Peter Mason

Head of Product Platform Science and Technology

Ervaxx Ltd

Jens Kringelum

Director, Genomic Immuno-Oncology

Exaxion Biotech

Scott Burkholz

Bioinformatics Scientist

Flow Pharma

Jennie Lill

Senior Director of Proteomics & NGS

Genentech

Ingunn Stromnes

Assistant Professor

University of Minnesota

Edward Samuel

SVP Manufacturing

Achilles Therapeutics

Chris Diehnelt

Associate Research Professor

Arizona State University

Tamara Ouspenskaia

Postdoctoral Fellow

Broad Institute

Julie Rumble

Manager, Immunology Contract Services

Cayman Chemical

David Reardon

Clinical Director, Center for NeuroOncology

Dana-Farber Cancer Institute

Thomas Wickham

Senior Vice President, Discovery

Rubius Therapeutics

Niranjan Sardesai

Chief Executive Officer

Geneos Therapeutics

Marc Wolfgang

Vice President of Technical Operations

Neon Therapeutics

Agnete Fredriksen

Chief Scientific Officer

Vaccibody

Heinz Lubenau

Chief Operating Officer

Vaximm

Kaidre Bendjama

Project Leader, Personalized Cancer Vaccines

Transgene

Lelia Delamarre

Senior Scientist, Cancer Immunology Research

Genentech

Andrew Allen

Chief Executive Officer

Gritstone Oncology

Willem-Jan Krebber

Chief Operating Officer

ISA Pharmaceuticals

Trevor Clancy

Chief Scientific Officer & Co-Founder

OncoImmunity

Trishul Shah

Director of Business Development

PolyPeptide Group

Sean Boyle

Senior Director, Bioinformatics Applications

Personalis Inc